当前位置:首页 - 行情中心 - 永安药业(002365) - 财务分析 - 现金流量表

永安药业

(002365)

  

流通市值:44.40亿  总市值:53.28亿
流通股本:2.46亿   总股本:2.95亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金393,496,343.75191,168,337.1868,377,965.49658,699,780.62
  收到的税费返还13,486,863.476,926,520.5628,713,253.5121,847,313.41
  收到其他与经营活动有关的现金2,355,922.771,339,713.849,660,643.3147,639,324.51
  经营活动现金流入小计409,339,129.99199,434,571.5906,751,862.31728,186,418.54
  购买商品、接受劳务支付的现金253,628,438.71115,843,390.49571,567,824.89454,536,610.75
  支付给职工以及为职工支付的现金67,744,885.6642,220,940.25112,714,827.887,819,430.9
  支付的各项税费13,397,465.246,489,998.838,844,915.9135,190,269.55
  支付其他与经营活动有关的现金23,386,789.7610,178,307.677,911,612.1757,345,778.51
  经营活动现金流出小计358,157,579.37174,732,637.14801,039,180.77634,892,089.71
  经营活动产生的现金流量净额51,181,550.6224,701,934.36105,712,681.5493,294,328.83
二、投资活动产生的现金流量:
  收回投资收到的现金380,710,244.38122,998,098.741,684,200,279.76913,357,027.83
  取得投资收益收到的现金9,603,224.084,525,753.3835,305,388.4423,741,381.11
  处置固定资产、无形资产和其他长期资产收回的现金净额2,7172,7171,893,443.721,174,176
  投资活动现金流入小计390,316,185.46127,526,569.121,721,399,111.92938,272,584.94
  购建固定资产、无形资产和其他长期资产支付的现金32,199,901.9520,010,736.75118,043,778.9989,758,369.37
  投资支付的现金442,121,223.62215,858,044.151,650,739,320.93986,870,092.93
  支付其他与投资活动有关的现金---7,500,000
  投资活动现金流出小计474,321,125.57235,868,780.91,768,783,099.921,084,128,462.3
  投资活动产生的现金流量净额-84,004,940.11-108,342,211.78-47,383,988-145,855,877.36
三、筹资活动产生的现金流量:
  取得借款收到的现金15,000,000-40,000,00020,600,000
  收到其他与筹资活动有关的现金780,723.23-600,000-
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计15,780,723.23-40,600,00020,600,000
  偿还债务支付的现金21,000,00010,000,00010,500,00010,000,000
  分配股利、利润或偿付利息支付的现金495,348.64238,862.5135,816,071.8641,140,099.2
  其中:子公司支付给少数股东的股利、利润--6,000,000-
  支付其他与筹资活动有关的现金16,292,817.5416,292,817.5431,683,171.4524,183,171.45
  筹资活动现金流出小计37,788,166.1826,531,680.0577,999,243.3175,323,270.65
  筹资活动产生的现金流量净额-22,007,442.95-26,531,680.05-37,399,243.31-54,723,270.65
四、汇率变动对现金及现金等价物的影响1,865,228.081,418,210.485,247,639.516,206,051.97
五、现金及现金等价物净增加额-52,965,604.36-108,753,746.9926,177,089.74-101,078,767.21
  加:期初现金及现金等价物余额320,405,292.96320,405,292.96294,228,203.22294,228,203.22
  期末现金及现金等价物余额267,439,688.6211,651,545.97320,405,292.96193,149,436.01
补充资料:
  净利润8,556,158.69-59,707,704.78-
  资产减值准备444,891-18,286,031.52-
  固定资产和投资性房地产折旧55,287,353.69-109,414,917.99-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧55,287,353.69-109,414,917.99-
  无形资产摊销1,729,949.17-3,416,243.2-
  处置固定资产、无形资产和其他长期资产的损失-32,631.44-326,208.7-
  固定资产报废损失--94,814.46-
  公允价值变动损失-2,004,491.16--4,431,333.86-
  财务费用-658,520.54--8,057,684.54-
  投资损失-11,461,930.22--39,679,131.94-
  递延所得税-3,238,406.82--16,924,772.12-
  其中:递延所得税资产减少-1,763,382.57-5,418,711.22-
    递延所得税负债增加-1,475,024.25--22,343,483.34-
  存货的减少-7,052,303.73--25,280,041.79-
  经营性应收项目的减少31,376,196.77-36,676,919.33-
  经营性应付项目的增加-20,294,174.27--28,194,407.83-
  现金的期末余额267,439,688.6-320,405,292.96-
  减:现金的期初余额320,405,292.96-294,228,203.22-
  现金及现金等价物的净增加额-52,965,604.36-26,177,089.74-
公告日期2025-08-282025-04-292025-04-102024-10-30
审计意见(境内)标准无保留意见
TOP↑